W738 (Alfuzosin hydrochloride extended-release 10 mg)

Pill imprint W738 has been identified as Alfuzosin hydrochloride extended-release 10 mg.

Alfuzosin is used in the treatment of benign prostatic hyperplasia and belongs to the drug class antiadrenergic agents, peripherally acting. There is no proven risk in humans during pregnancy. Alfuzosin 10 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for W738

Alfuzosin hydrochloride extended-release 10 mg W738
Alfuzosin hydrochloride extended-release
Imprint:
W738
Strength:
10 mg
Color:
White & Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Wockhardt Limited

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)